#Latest news with #BritishdrugmakerReuters6 days agoBusinessReutersGSK's blood cancer drug gets EU approval for multiple myelomaJuly 24 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Thursday the European Union has approved the company's blood cancer drug Blenrep for the treatment of relapsed or refractory multiple myeloma.
Reuters6 days agoBusinessReutersGSK's blood cancer drug gets EU approval for multiple myelomaJuly 24 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Thursday the European Union has approved the company's blood cancer drug Blenrep for the treatment of relapsed or refractory multiple myeloma.
6 days ago
